On the public citation graph
Medications for opioid use disorders: clinical and pharmacological considerations
0 signed · 71 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd002207.pub4openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd002208openalex-snapshot
Methadone maintenance at different dosages for opioid dependence
inferredcites →https://doi.org/10.1016/j.biopsych.2006.01.006openalex-snapshot
Buprenorphine Reduces Alcohol Drinking Through Activation of the Nociceptin/Orphanin FQ-NOP Receptor System
inferredcites →https://doi.org/10.1016/j.drugalcdep.2018.04.029openalex-snapshot
Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies
inferredcites →https://doi.org/10.1016/j.jsat.2019.07.005openalex-snapshot
Buprenorphine in the United States: Motives for abuse, misuse, and diversion
inferredcites →https://doi.org/10.1016/j.tins.2007.01.004openalex-snapshot
Sensing and expressing homeostatic synaptic plasticity
inferredcites →https://doi.org/10.1016/s0140-6736(11)60358-9openalex-snapshot
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
inferredcites →https://doi.org/10.1016/s0140-6736(18)33078-2openalex-snapshot
Management of opioid use disorder in the USA: present status and future directions
inferredcites →https://doi.org/10.1016/s2215-0366(16)00104-8openalex-snapshot
Neurobiology of addiction: a neurocircuitry analysis
inferredcites →https://doi.org/10.1038/bjp.2008.100openalex-snapshot
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
inferredcites →https://doi.org/10.1038/npp.2015.258openalex-snapshot
Dynorphin, Dysphoria, and Dependence: the Stress of Addiction
inferredcites →https://doi.org/10.1073/pnas.1010654108openalex-snapshot
Addiction: Beyond dopamine reward circuitry
inferredcites →https://doi.org/10.1097/adm.0000000000000045openalex-snapshot
A Review of Buprenorphine Diversion and Misuse
inferredcites →https://doi.org/10.1176/appi.ajp.162.8.1403openalex-snapshot
The Neural Basis of Addiction: A Pathology of Motivation and Choice
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4774188openalex-extracted
Closing the Opioid Use Disorder Treatment Gap: Expanding Nurse Practitioners' Prescriptive Authority
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.9041openalex-snapshot
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2022.4020openalex-snapshot
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1002/wps.21073openalex-snapshot
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
inferred← citeshttps://doi.org/10.1007/978-3-031-09936-6_1openalex-snapshot
A Brief History of Opioids and the Evolution of Concepts Associated with Substance Use Disorders
inferred← citeshttps://doi.org/10.1007/s11469-022-00941-8openalex-snapshot
Characterizing Impulsivity in Individuals with Heroin Use Disorder
inferred← citeshttps://doi.org/10.1007/s12664-025-01868-3openalex-snapshot
Opioid dependence in patients with pain in chronic pancreatitis an emerging problem
inferred← citeshttps://doi.org/10.1007/s40262-023-01288-6openalex-snapshot
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
inferred← citeshttps://doi.org/10.1007/s40263-026-01300-0openalex-snapshot
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them
inferred← citeshttps://doi.org/10.1016/b978-0-443-45863-7.00095-0openalex-snapshot
Drug use disorders in women
inferred← citeshttps://doi.org/10.1016/j.anclin.2026.04.001openalex-snapshot
Peripartum Management for Patients Receiving Medication for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.dadr.2026.100424openalex-snapshot
Relationship between extended-release buprenorphine adherence and reduced risk of return to use in patients with opioid use disorder: A retrospective claims data analysis
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108886openalex-snapshot
An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112628openalex-snapshot
The opioid epidemic in rural communities: Can telehealth increase access to medications for opioid use disorder and offset barriers to care?
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103786openalex-snapshot
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209271openalex-snapshot
Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare
inferred← citeshttps://doi.org/10.1016/j.jpet.2025.103731openalex-snapshot
Sinomenine alleviates cancer-induced bone pain by promoting p65 ubiquitination and modulating microglial polarization
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108656openalex-snapshot
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2023.109524openalex-snapshot
Advances in the characterization of negative affect caused by acute and protracted opioid withdrawal using animal models
inferred← citeshttps://doi.org/10.1016/j.pbb.2022.173473openalex-snapshot
Sensitivity of a fentanyl-vs.-social interaction choice procedure to environmental and pharmacological manipulations
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c01029openalex-snapshot
Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2
inferred← citeshttps://doi.org/10.1038/s41380-025-03168-wopenalex-snapshot
Exploring the therapeutic potential of psychedelics in treating substance use disorders
inferred← citeshttps://doi.org/10.1038/s41398-021-01228-7openalex-snapshot
Metabolomics reveals biomarkers of opioid use disorder
inferred← citeshttps://doi.org/10.1038/s41598-024-60759-3openalex-snapshot
Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice
inferred← citeshttps://doi.org/10.1071/py25035openalex-snapshot
Understanding issues of driving safety and transport utilisation among clients receiving opioid agonist treatment: a cross-sectional survey in New South Wales, Australia
inferred← citeshttps://doi.org/10.1080/00952990.2025.2571414openalex-snapshot
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorder
inferred← citeshttps://doi.org/10.1080/02791072.2023.2230571openalex-snapshot
Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment
inferred← citeshttps://doi.org/10.1080/10826084.2026.2670613openalex-snapshot
Why Participants Leave: A Qualitative Study Exploring Dropout from a Medication for Opioid Use Disorder (MOUD) Clinical Trial
inferred← citeshttps://doi.org/10.1080/13543776.2022.2049240openalex-snapshot
Dopamine D3 receptor ligands: a patent review (2014–2020)
inferred← citeshttps://doi.org/10.1080/15401383.2024.2413631openalex-snapshot
Perinatal Substance Use in Film: An Ecological Exploration of Maternal Wellbeing Using the Documentary Higher Love
inferred← citeshttps://doi.org/10.1093/cid/ciaa064openalex-snapshot
“Rapid Start” Treatment to End the (Other) Epidemic: Walking the Tightrope Without a Net
inferred← citeshttps://doi.org/10.1093/oncolo/oyae176openalex-snapshot
Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids
inferred← citeshttps://doi.org/10.1097/adm.0000000000001644openalex-snapshot
Appropriate Clinical Response Following Opioid Overdose: A Retrospective Analysis Within the Veterans Health Administration System
inferred← citeshttps://doi.org/10.1111/adb.12970openalex-snapshot
Brain volume changes after long‐term injectable opioid treatment: A longitudinal voxel‐based morphometry study
inferred← citeshttps://doi.org/10.1111/add.15814openalex-snapshot
Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort
inferred← citeshttps://doi.org/10.1111/cns.70034openalex-snapshot
Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability
inferred← citeshttps://doi.org/10.1111/dar.13885openalex-snapshot
Rotation from methadone to buprenorphine using a micro‐dosing regime in patients with opioid use disorder and serious mental illness: A case series
inferred← citeshttps://doi.org/10.1111/dar.14005openalex-snapshot
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
inferred← citeshttps://doi.org/10.1172/jci171995openalex-snapshot
Targeting mitochondrial dynamics of morphine-responsive dopaminergic neurons ameliorates opiate withdrawal
inferred← citeshttps://doi.org/10.1177/00914509241309110openalex-snapshot
Physical Accessibility Barriers to Medications for Opioid Use Disorder Treatment: A Qualitative Study of Perspectives from Women with Opioid Use Disorder and Health and Criminal Legal Professionals
inferred← citeshttps://doi.org/10.1177/10783903261443980openalex-snapshot
Imprinted Arousal Pattern (IAP): A Transdiagnostic Clinical Reasoning for Compulsive Behaviors
inferred← citeshttps://doi.org/10.1177/28314425261431948openalex-snapshot
Effects of Psychedelics Lysergic Acid Diethylamide and R (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice
inferred← citeshttps://doi.org/10.1186/s13011-024-00628-4openalex-snapshot
Understanding MAT access in the context of unused MAT capacity in the United States: when increasing rural MAT capacity is not enough
inferred← citeshttps://doi.org/10.1186/s13011-025-00678-2openalex-snapshot
“Now that we’ve opened the door”: challenges recovery home directors face when housing residents receiving medication for opioid use disorder
inferred← citeshttps://doi.org/10.1371/journal.pone.0298341openalex-snapshot
The synthetic opioid fentanyl increases HIV replication in macrophages
inferred← citeshttps://doi.org/10.15288/jsad.22-00049openalex-snapshot
Characterization of Unintentional Deaths Among Buprenorphine Users
inferred← citeshttps://doi.org/10.2174/0122106766304121240718112939openalex-snapshot
Adolescent Substance Use, and Related Emergency Room Visits, and Continuum of Care
inferred← citeshttps://doi.org/10.31486/toj.23.0074openalex-snapshot
At a Crossroads: Opioid Use Disorder, the X-Waiver, and the Road Ahead
inferred← citeshttps://doi.org/10.3389/fdgth.2026.1769417openalex-snapshot
Reductions in substance use-related parenting behaviors after participation in a digitally delivered parenting intervention
inferred← citeshttps://doi.org/10.3389/fnmol.2023.1239599openalex-snapshot
Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications
inferred← citeshttps://doi.org/10.3389/fpsyt.2023.1247961openalex-snapshot
Association between body mass index and treatment completion in extended-release naltrexone-treated patients with opioid dependence
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1682094openalex-snapshot
Global and regional burdens of opioid use disorder from 1990 to 2021, with future forecasts to 2050: a systematic analysis for the global burden of disease study 2021
inferred← citeshttps://doi.org/10.3389/fpubh.2026.1774410openalex-snapshot
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
inferred← citeshttps://doi.org/10.3390/molecules31193463openalex-snapshot
Impact of Cannabidiol and Its Synthetic Derivative on Fentanyl Consumption and Fentanyl-Induced Neurometabolic Alterations in Mice
inferred← citeshttps://doi.org/10.3390/pharmaceutics16010084openalex-snapshot
Vaccines to Treat Substance Use Disorders: Current Status and Future Directions
inferred← citeshttps://doi.org/10.5498/wjp.v11.i9.543openalex-snapshot
Recent advances in the treatment of opioid use disorders–focus on long-acting buprenorphine formulations
inferred← citeshttps://doi.org/10.64898/2026.03.18.712659openalex-snapshot
Parabrachial CGRP Neurons Regulate Opioid Reinforcement
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.